Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies (Q44817963)

6 December 2017

Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies (English)

1 reference

6 December 2017

0 references

1 reference

8

Jean Bousquet

1 reference

6 December 2017

Paul Chervinsky

1

1 reference

6 December 2017

George Philip

2

1 reference

6 December 2017

Marie-Pierre Malice

3

1 reference

6 December 2017

Jose Bardelas

4

1 reference

6 December 2017

Anjuli Nayak

5

1 reference

6 December 2017

Jean-Louis Marchal

6

1 reference

6 December 2017

Janet van Adelsberg

7

1 reference

6 December 2017

Carol A Tozzi

9

1 reference

6 December 2017

Theodore F Reiss

10

1 reference

6 December 2017

1 March 2004

1 reference

Annals of Allergy, Asthma & Immunology

6 December 2017

1 reference

6 December 2017

92

1 reference

6 December 2017

3

1 reference

6 December 2017

367-373

1 reference

Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC).

6 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961576-1

7 January 2021

Interpreting atmospheric pollen counts for use in clinical allergy: allergic symptomology

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961576-1

7 January 2021

Allergen-Induced Release of Sulphidopeptide Leukotrienes (SRS-A) and LTB4in Allergic Rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961576-1

7 January 2021

Correlations between complaints, inflammatory cells and mediator concentrations in nasal secretions after nasal allergen challenge and during natural allergen exposure

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961576-1

7 January 2021

Leukotriene C4 release in upper respiratory mucosa during natural exposure to ragweed in ragweed-sensitive children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961576-1

7 January 2021

Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961576-1

7 January 2021

Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961576-1

7 January 2021

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961576-1

7 January 2021

Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961576-1

7 January 2021

Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961576-1

7 January 2021

Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961576-1

7 January 2021

Montelukast improves symptoms of seasonal allergic rhinitis over a 4‐week treatment period

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961576-1

7 January 2021

Effect of tree and grass pollens and fungal spores on spring allergic rhinitis: a comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961576-1

7 January 2021

Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961576-1

7 January 2021

Changes in severity of symptoms of asthma and allergic rhinitis due to air pollutants

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961576-1

7 January 2021

Time series analyses of respiratory responses to indoor and outdoor environmental phenomena

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961576-1

7 January 2021

10.1016/S1081-1206(10)61576-1

Identifiers

DOI

1 reference

6 December 2017

1 reference